[HTML][HTML] Headache after vaccination: an update on recent clinical trials and real-world reporting

KN Garces, AN Cocores, PJ Goadsby… - Current Pain and …, 2022 - Springer
Abstract Purpose of Review The aim of this review is to characterize headache as a vaccine
adverse event (VAE) in clinical trials. Recent Findings Of the recent phase III vaccine RCTs …

[HTML][HTML] Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting

KN Garces, AN Cocores, PJ Goadsby… - Current Pain and …, 2022 - ncbi.nlm.nih.gov
Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting

KN Garces, AN Cocores… - Current pain and …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose of review The aim of this review is to characterize headache as a vaccine adverse
event (VAE) in clinical trials. Recent findings Of the recent phase III vaccine RCTs (non …

Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting.

KN Garces, AN Cocores, PJ Goadsby… - Current Pain and …, 2022 - europepmc.org
Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting

KN Garces, AN Cocores, PJ Goadsby… - Current Pain and …, 2022 - search.proquest.com
Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting
Page 1 Vol.:(0123456789) 1 3 Current Pain and Headache Reports (2022) 26:895–918 …

Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting.

KN Garces, AN Cocores, PJ Goadsby… - Current Pain and …, 2022 - europepmc.org
Of the recent phase III vaccine RCTs (non-COVID-19), 53 studies reported on headache (13
infectious agents). The median rate (interquartile range) of headache was 15.6%(IQR: 9.6 …